Follow RSS for latest reports on this topicInfertility - Market Research and Reports

Infertility is fundamentally the inability to conceive a baby. Infertility also refers to the state of a woman who is unable to carry a pregnancy to full term. There are many biological causes of infertility, including some that medical intervention can treat. Infertility has increased by 4 percent since the 1980s, mostly from problems with fecundity due to an increase in age. About 40 percent of the issues involved with infertility are due to the man, another 40 percent due to the woman, and 20 percent result from complications with both partners.
Women who are fertile experience a natural period of fertility before and during ovulation, and they are naturally infertile during the rest of the menstrual cycle. Fertility awareness methods are used to discern when these changes occur by tracking changes in cervical mucus or basal body temperature.

Source: Wikipedia

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found 26 reports that matched your search.

Refine your search, and find more matches, using the form above.


Published by: Azoth Analytics

Prices Starting From:

Genito-Urinary Drugs Market Global Report 2017 Including: Hormonal Contraceptives, Drugs For Benign Prostatic Hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Harmonal Replacement Therapy, Diuretics Covering: Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Abb [Report Updated: 17-07-2017]

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases.

Some of the major drugs in the market include Avastin, Trimethoprim/sulfamethoxazolRead More >>>


Published by: The Business Research Company

Prices Starting From:

Infertility Treatment Market by Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2022 [Report Updated: 08-05-2017]

The global infertility treatment market is expected to reach USD 2.05 billion by 2022 from USD 1.24 billion in 2017, at a CAGR of 10.6% from 2017 to 2022. Growth in this market is primarily driven by factors such as the continuous decline in fertility rates; increasing public-private investments, funds, and grants; growing public awareness about infertility and the available treatment options; the...Read More >>>


Published by: MarketsandMarkets

Prices Starting From:

Male Infertility Treatment Market: By Techniques (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, SPA, Sperm Agglutination, CASA),By Disorders (Idiopathic, varicocele, chryptrochidism, Obstructions, Testicular failure, Semen Disorders) & By Region-Forecast (2016-2021) [Report Updated: 26-02-2016]

Male infertility can be defined as the inability to cause pregnancy in a fertile female by male counterpart. Generally male infertility is caused due to low sperm count, hormonal problem or presence of low number of motile sperms. Fertile male requires normal functioning of hypothalamus, pituitary gland, and testes. However some of the other common causes of increasing infertility in male includes...Read More >>>


Published by: Industry ARC

Prices Starting From:


Published by: MarketsandMarkets

Prices Starting From:

We Stock...